UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Author | Type
Jump to: B | C | D | F | G | H | M | N | O | P | R | S | T | V | W
Number of items: 41.


Bentzen, SM; Saunders, MI; Dische, S; Parmar, MK; (2001) Accelerated radiotherapy vs. chemoradiation in non-small cell lung cancer: quantifying the hazards. Radiother Oncol , 58 (1) pp. 91-92.

Bilanges, B; Varrault, A; Mazumdar, A; Pantaloni, C; Hoffmann, A; Bockaert, J; Spengler, D; (2001) Alternative splicing of the imprinted candidate tumor suppressor gene ZAC regulates its antiproliferative and DNA binding activities. Oncogene , 20 (10) pp. 1246-1253. 10.1038/sj.onc.1204237.

Boddy, AV; Griffin, MJ; Sludden, J; Thomas, HD; Fishwick, K; Wright, JG; Plummer, ER; (2001) Pharmacological study of paclitaxel duration of infusion combined with GFR-based carboplatin in the treatment of ovarian cancer. CANCER CHEMOTH PHARM , 48 (1) 15 - 21.

Bowman, KJ; Newell, DR; Calvert, AH; Curtin, NJ; (2001) Differential effects of the poly (ADP-ribose) polymerase (PARP) inhibitor NU1025 on topoisomerase I and II inhibitor cytotoxicity in L1210 cells in vitro. BRIT J CANCER , 84 (1) 106 - 112. 10.1054/bjoc.2000.1555.


Cerone, MA; Londono-Vallejo, JA; Bacchetti, S; (2001) Telomere maintenance by telomerase and by recombination can coexist in human cells. Hum Mol Genet , 10 (18) pp. 1945-1952.

Cheung, VG; Nowak, N; Jang, W; Kirsch, IR; Zhao, S; Chen, XN; Furey, TS; (2001) Integration of cytogenetic landmarks into the draft sequence of the human genome. NATURE , 409 (6822) 953 - 958.

Cooke, SP; Boxer, GM; Lawrence, L; Pedley, RB; Spencer, DIR; Begent, RHJ; Chester, KA; (2001) A strategy for antitumor vascular therapy by targeting the vascular endothelial growth factor : receptor complex. CANCER RES , 61 (9) 3653 - 3659.


Deloukas, P; Matthews, LH; Ashurst, J; Burton, J; Gilbert, JGR; Jones, M; Stavrides, G; (2001) The DNA sequence and comparative analysis of human chromosome 20. NATURE , 414 (6866) 865 - U3.


Flynn, AA; Boxer, GM; Begent, RHJ; Pedley, RB; (2001) Relationship between tumour morphology, antigen and antibody distribution measured by fusion of digital phosphor and photographic images. CANCER IMMUNOL IMMUN , 50 (2) 77 - 81.

Flynn, AA; Green, AJ; Pedley, RB; Boxer, GM; Boden, R; Begent, RH; (2001) A mouse model for calculating the absorbed beta-particle dose from (131)I- and (90)Y-labeled immunoconjugates, including a method for dealing with heterogeneity in kidney and tumor. Radiat Res , 156 (1) pp. 28-35.

Flynn, AA; Pedley, RB; Green, AJ; Boxer, GM; Boden, R; Begent, RH; (2001) Optimizing radioimmunotherapy by matching dose distribution with tumor structure using 3D reconstructions of serial images. Cancer Biother Radiopharm , 16 (5) pp. 391-400. 10.1089/108497801753354294.

Flynn, AA; Pedley, RB; Green, AJ; Boxer, GM; Boden, R; Dearling, J; Bhatia, J; (2001) Effectiveness of radiolabelled antibodies for radio-immunotherapy in a colorectal xenograft model: a comparative study using the linear-quadratic formulation. INT J RADIAT BIOL , 77 (4) 507 - 517.


Green, AJ; Johnson, CJ; Adamson, KL; Begent, RHJ; (2001) Mathematical model of antibody targeting: important parameters defined using clinical data. PHYS MED BIOL , 46 (6) 1679 - 1693.

Gregson, SJ; Howard, PW; Hartley, JA; Brooks, NA; Adams, LJ; Jenkins, TC; Kelland, LR; (2001) Design, synthesis, and evaluation of a novel pyrrolobenzodiazepine DNA-interactive agent with highly efficient cross-linking ability and potent cytotoxicity. J MED CHEM , 44 (5) 737 - 748. 10.1021/jm001064n.

Guiducci, C; Cerone, MA; Bacchetti, S; (2001) Expression of mutant telomerase in immortal telomerase-negative human cells results in cell cycle deregulation, nuclear and chromosomal abnormalities and rapid loss of viability. Oncogene , 20 (6) pp. 714-725. 10.1038/sj.onc.1204145.


Hartley, JC; Kaye, S; Stevenson, S; Bennett, J; Ridgway, G; (2001) PCR detection and molecular identification of Chlamydiaceae species. JOURNAL OF CLINICAL MICROBIOLOGY , 39 (9) pp. 3072-3079. 10.1128/JCM.39.9.3072-3079.2001.


Maxwell-Armstrong, CA; Durrant, LG; Buckley, TJD; Scholefield, JH; Robins, RA; Fielding, K; Monson, JRT; (2001) Randomized double-blind phase II survival study comparing immunization with the anti idiotypic monoclonal antibody 105AD7 against placebo in advanced colorectal cancer. BRIT J CANCER , 84 (11) 1443 - 1446.

McGurk, CJ; McHugh, PJ; Tilby, MJ; Grimaldi, KA; Hartley, JA; (2001) Measurement of covalent drug-DNA interactions at the nucleotide level in cells at pharmacologically relevant doses. METHOD ENZYMOL , 340 358 - 376.

McHugh, PJ; Spanswick, VJ; Hartley, JA; (2001) Repair of DNA interstrand crosslinks: molecular mechanisms and clinical relevance. Lancet Oncol , 2 (8) pp. 483-490. 10.1016/S1470-2045(01)00454-5.

Meyer, T; Cole, LA; Richman, PI; Mitchell, HD; Myers, J; Rustin, GJ; (2001) High levels of hCG in choriocarcinoma can result in renal failure and a false-negative pregnancy test in men. Clin Oncol (R Coll Radiol) , 13 (4) pp. 301-303.

Meyer, T; Nelstrop, AE; Mahmoudi, M; Rustin, GJ; (2001) Weekly cisplatin and oral etoposide as treatment for relapsed epithelial ovarian cancer. Ann Oncol , 12 (12) pp. 1705-1709.

Miles, DW; Smith, IE; Coleman, RE; Calvert, AH; Lind, MJ; (2001) A phase II study of pemetrexed disodium (LY231514) in patients with locally recurrent or metastatic breast cancer. EUR J CANCER , 37 (11) 1366 - 1371.


Ndisang, D; Budhram-Mahadeo, V; Pedley, RBAL; D, S; (2001) The Brn-3a transcription factor plays a key role in regulating the growth of cervical cells in vivo. Oncogene , 20 pp. 4899-4903.


O'Nions, J; Brooks, LA; Sullivan, A; Bell, A; Dunne, B; Rozycka, M; Reddy, A; (2001) p73 is over-expressed in vulval cancer principally as the Delta 2 isoform. Br J Cancer , 85 (10) pp. 1551-1556. 10.1054/bjoc.2001.2138.

Okkenhaug, K; Vanhaesebroeck, B; (2001) New responsibilities for the PI3K regulatory subunit p85 alpha. Sci STKE , 2001 (65) pe1-. 10.1126/stke.2001.65.pe1.


Parkinson, MC; Harland, SJ; Harnden, P; Sandison, A; (2001) The role of the histopathologist in the management of testicular germ cell tumour in adults. HISTOPATHOLOGY , 38 (3) 183 - 194.

Pedley, RB; Hill, SA; Boxer, GM; Flynn, AA; Boden, R; Watson, R; Dearling, J; (2001) Eradication of colorectal xenografts by combined radioimmunotherapy and combretastatin A-4 3-O-phosphate. CANCER RES , 61 (12) 4716 - 4722.


Rustin, GJ; Marples, M; Nelstrop, AE; Mahmoudi, M; Meyer, T; (2001) Use of CA-125 to define progression of ovarian cancer in patients with persistently elevated levels. J Clin Oncol , 19 (20) pp. 4054-4057. 10.1200/jco.2001.19.20.4054.


Sierens, J; Hartley, JA; Campbell, MJ; Leathem, AJC; Woodside, JV; (2001) Effect of phytoestrogen and antioxidant supplementation on oxidative DNA damage assessed using the comet assay. MUTAT RES-DNA REPAIR , 485 (2) 169 - 176.

Smith, PG; Thomas, HD; Barlow, HC; Griffin, RJ; Golding, BT; Calvert, AH; Newell, DR; (2001) In vitro and in vivo properties of novel nucleoside transport inhibitors with improved pharmacological properties that potentiate antifolate activity. CLIN CANCER RES , 7 (7) 2105 - 2113.

Smyth, J; Boneterre, ME; Schellens, J; Calvert, H; Greim, G; Wanders, J; Hanauske, A; (2001) Activity of the dolastatin analogue, LU103793, in malignant melanoma. ANN ONCOL , 12 (4) 509 - 511.

Stein, RC; (2001) Prospects for phosphoinositide 3-kinase inhibition as a cancer treatment. Endocr Relat Cancer , 8 (3) pp. 237-248.

Swanton, C; Jones, N; (2001) Strategies in subversion: de-regulation of the mammalian cell cycle by viral gene products. INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY , 82 (1) pp. 3-13. 10.1046/j.1365-2613.2001.00165.x.


Todd, R; Boddy, AV; Verrill, M; Sludden, J; Griffin, MJ; Elliott, S; Fishwick, K; (2001) Phase I and pharmacological study of CT-2103, a poly(L-glutamic acid)-paclitaxel conjugate. Clinical Cancer Research , 7 (11) 115 - ?.

Tolner, B; Hartley, JA; Hochhauser, D; (2001) Transcriptional regulation of topoisomerase II alpha at confluence and pharmacological modulation of expression by bis-benzimidazole drugs. MOL PHARMACOL , 59 (4) 699 - 706.


Vanhaesebroeck, B; Leevers, SJ; Ahmadi, K; Timms, J; Katso, R; Driscoll, PC; Woscholski, R; (2001) Synthesis and function of 3-phosphorylated inositol lipids. ANNUAL REVIEW OF BIOCHEMISTRY , 70 pp. 535-602. 10.1146/annurev.biochem.70.1.535.

Varrault, A; Bilanges, B; Mackay, DJ; Basyuk, E; Ahr, B; Fernandez, C; Robinson, DO; (2001) Characterization of the methylation-sensitive promoter of the imprinted ZAC gene supports its role in transient neonatal diabetes mellitus. J Biol Chem , 276 (22) pp. 18653-18656. 10.1074/jbc.C100095200.

von Schlippe, M; Fowler, CJ; Harland, SJ; (2001) Cisplatin neurotoxicity in the treatment of metastatic germ cell tumour: time course and prognosis. BRIT J CANCER , 85 (6) 823 - 826. 10.1054/bjoc.2001.2006.


Webley, SD; Francis, RJ; Pedley, RB; Sharma, SK; Begent, RHJ; Hartley, JA; Hochhauser, D; (2001) Measurement of the critical DNA lesions produced by antibody-directed enzyme prodrug therapy (ADEPT) in vitro, in vivo and in clinical material. BRIT J CANCER , 84 (12) 1671 - 1676. 10.1054/bjoc.2001.1843.

Wickremasinghe, RG; Ganeshaguru, K; Jones, DT; Lindsay, C; Spanswick, VJ; Hartley, JA; Wadhwa, M; (2001) Autologous plasma activates Akt/protein kinase B and enhances basal survival and resistance to DNA damage-induced apoptosis in B-chronic lymphocytic leukaemia cells. Br J Haematol , 114 (3) pp. 608-615.

Wright, JG; Boddy, AV; Highley, M; Fenwick, J; McGill, A; Calvert, AH; (2001) Estimation of glomerular filtration rate in cancer patients. BRIT J CANCER , 84 (4) 452 - 459.

This list was generated on Sun Nov 27 03:09:55 2016 GMT.